4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0000947871-21-000349
Director sold 66,202 shares at an average $27.95 ($1,850,339)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2021-03-16 | Sale | −41,353 | $27.72 | $1,146,305 | 2,486,082 | I: show line 1 in the form |
| ORBIMED ADVISORS LLC Director | 2021-03-17 | Sale | −18,790 | $28.43 | $534,200 | 2,467,292 | I: show line 2 in the form |
| ORBIMED ADVISORS LLC Director | 2021-03-18 | Sale | −6,059 | $28.03 | $169,834 | 2,461,233 | I: show line 3 in the form |
| Open-market sales · 66,202 sh · avg $27.95 · $1,850,339 | |||||||
Loading xslF345X03/ownership.xml…